Purpose: To describe the morphological characteristics of macular edema (ME) of different
origins using spectral domain optical coherence tomography (SD-OCT). Methods: This …

A diagnostic sign refers to a quantifiable biological parameter that is measured and
evaluated as an indicator of normal biological, pathogenic, or pharmacologic responses to a …

Objective To report the long-term efficacy and safety of the interleukin-6 receptor antagonist
tocilizumab for refractory uveitis-related macular edema (ME). Design Retrospective cohort …

Background: To report the 24-month efficacy and safety of the interleukin-6 receptor
antagonist tocilizumab (TCZ) for refractory uveitis-related macular edema (ME). Methods …

Purpose: Macular edema (ME) is a leading cause of visual loss in a range of retinal
diseases and despite the use of antivascular endothelial growth factor (anti-VEGF) agents …

Spectral-domain optical coherence tomography findings of the macula in 500 consecutive
patients with uveitis | Eye Skip to main content Thank you for visiting nature.com. You are using …

Macular edema accompanies many ocular pathologies, affecting visual function and is an
important factor in treatment decisions and disease outcome. Though visual acuity is …

Retinal vein occlusion (RVO) is a significant cause of vision loss, characterized by the
occlusion of retinal veins, leading to conditions such as central retinal vein occlusion …

Most uveitis entities are rare diseases but, taken together, are responsible for 5–10% of
worldwide visual impairment which largely affects persons of working age. As with many …

Purpose: Macular pathology, including macular holes (MHs), epiretinal membranes (ERMs),
and macular edema, is a cause of irreversible vision loss in the setting of uveitis. Medical …